MedPath

Diclofenac Potassium

Diclofenac Potassium Tablets, USP Rx only Prescribing Information

Approved
Approval ID

94898228-c595-4fd6-acc2-13dbdbde9c0e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 26, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diclofenac Potassium Tablets

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-9720
Application NumberANDA215750
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diclofenac Potassium Tablets
Product Specifications
Route of AdministrationORAL
Effective DateDecember 8, 2022
FDA Product Classification

INGREDIENTS (9)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
DICLOFENAC POTASSIUMActive
Quantity: 50 mg in 1 1
Code: L4D5UA6CB4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diclofenac Potassium - FDA Drug Approval Details